Letter in response to the Wedlake et al. paper 'Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies'

Eur J Cancer. 2013 May;49(7):1783-6. doi: 10.1016/j.ejca.2012.12.029. Epub 2013 Feb 26.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
  • Female
  • Gastrointestinal Diseases / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Pelvic Neoplasms / radiotherapy*
  • Radiation Injuries / prevention & control*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors